Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections

By Zhou Dongming   Ertl Hildegund CJ  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 1, 2006-01 ,pp. : 63-72

Informa Healthcare

Access to resources Recommend Favorite

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development

By Patterson L Jean   Robert-Guroff Marjorie  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 9, 2008-09 ,pp. : 1347-1363

Informa Healthcare

Access to resources Recommend Favorite

Galectins and their ligands: negative regulators of anti-tumor immunity

By Cedeno-Laurent Filiberto   Dimitroff Charles  

Glycoconjugate Journal, Vol. 29, Iss. 8-9, 2012-12 ,pp. : 619-625

Springer Publishing Company

Access to resources Recommend Favorite

In Vivo Antitumor Effect of Cytotoxic T Lymphocytes Engineered to Produce Interferon-gamma by Adenovirus-Mediated Genetic Transduction

By Abe J.   Wakimoto H.   Tsunoda R.   Okabe S.   Yoshida Y.   Aoyagi M.   Hirakawa K.   Hamada H.  

Biochemical and Biophysical Research Communications, Vol. 218, Iss. 1, 1996-01 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity

By Negri Donatella RM   Michelini Zuleika   Bona Roberta   Blasi Maria   Filati Piero   Leone Pasqualina   Rossi Alessandra   Franco Marina   Cara Andrea  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 739-750

Informa Healthcare

Access to resources Recommend Favorite